Akcea Therapeutics Inc

FDA Filings

This page includes the latest FDA filings for Akcea Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

USA

NASDAQ

AKCA

DUNS 079911419

FDA Registration(s)

FDA Filings

Device Company	Device	Date
NA Akcea Therapeutics, Inc.	Other Medication	2023-05-26
NA Akcea Therapeutics, Inc.	Other Medication	2023-05-19
Tegsedi Akcea Therapeutics, Inc.	Prescription Medication	2023-01-12
Tegsedi Akcea Therapeutics, Inc.	Prescription Medication	2022-07-02
Tegsedi Akcea Therapeutics, Inc.	Prescription Medication	2021-08-14
Tegsedi Akcea Therapeutics, Inc.	Prescription Medication	2020-08-29
Tegsedi Akcea Therapeutics, Inc.	Prescription Medication	2020-08-06
Tegsedi Akcea Therapeutics, Inc.	Prescription Medication	2019-12-05
Tegsedi Akcea Therapeutics, Inc.	Prescription Medication	2019-06-22
Tegsedi Akcea Therapeutics, Inc.	Prescription Medication	2019-05-29
NDC 72126-007 Akcea Therapeutics, Inc.	Tegsedi	2018-10-05

Similar & Related FDA Registered Companies

Related Finance Registrations

NCAGE Code	897W4	AKCEA THERAPEUTICS, INC.!DBA AKCEA THERAPEUTICS
CAGE Code	897W4	AKCEA THERAPEUTICS, INC. AKCEA THERAPEUTICS
S.A.M. Registration	897W4 [79911419]	AKCEA THERAPEUTICS, INC. AKCEA THERAPEUTICS
S.A.M. Registration	897W4 [79911419]	AKCEA THERAPEUTICS, INC. AKCEA THERAPEUTICS
DUNS	079911419	Akcea Therapeutics, Inc.
SEC	0001662524	AKCEA THERAPEUTICS, INC. of DELAWARE